Search results for "DOC"

Lipoprotein Subfractions in Metabolic Syndrome and Obesity: Clinical Significance and Therapeutic Approaches

2013

Small, dense low density lipoprotein (sdLDL) represents an emerging cardiovascular risk factor, since these particles can be associated with cardiovascular disease (CVD) independently of established risk factors, including plasma lipids. Obese subjects frequently have atherogenic dyslipidaemia, including elevated sdLDL levels, in addition to elevated triglycerides (TG), very low density lipoprotein (VLDL) and apolipoprotein-B, as well as decreased high density lipoprotein cholesterol (HDL-C) levels. Obesity-related co-morbidities, such as metabolic syndrome (MetS) are also characterized by dyslipidaemia. Therefore, agents that favourably modulate LDL subclasses may be of clinical value in t…

Fundamental movement skill proficiency and body composition measured by dual energy X-ray absorptiometry in eight-year-old children

2014

Objective: The main aim was to examine the association between fundamental movement skills (FMS) and objectively measured body composition using dual energy X-ray absorptiometry (DXA). Methods: Study of 304 eight-year-old children in Finland. FMS were assessed with the Test of Gross Motor Development, 2nd ed. (TGMD-2). Total body fat percentage (BF%), abdominal region fat percentage (AF%), and fat-free mass (FFM) were assessed by DXA. Waist circumference, height and weight were measured and International Obesity Task Force (IOTF) cut-off values for BMI were used for the definition of healthy weight and overweight/obesity. Results: Better FMS proficiency (object-control, locomotor, total FMS…

Effet anti-obésité des CLA : mythe ou réalité ?

2005

Conjugated linoleic acids (CLA) are positional and geometric isomers of linoleic acid. Inclusion of CLA in the diet provokes a rapid and marked decrease in body weight gain and adiposity in mice leading to a lipoatrophic syndrome. However, CLA supplementation raised fasting blood glucose and insulin concentrations and was associated with severe insulin resistance and liversteatosis. Conflicting results have been reported with regard to reduction of fat mass in humans. We have reviewed the publish literature regarding the effect of CLA on body composition in humans and animal models. These studies indicate that t10-c12 was the isomer that reduced adipose fat storage, however it also increase…

Two‐year effect of semaglutide 2.4 mg on control of eating in adults with overweight/obesity: STEP 5

2023

Background: The STEP 5 trial (NCT03693430) investigated once-weekly (OW) subcutaneous semaglutide 2.4 mg vs placebo for the treatment of overweight/obesity in adults over 2 years. Methods: Adults w ith B MI ≥ 3 0 k g/m2, or ≥27 kg/m2 and ≥ 1 weight-related comorbidity, without diabetes, were randomized 1:1 to semaglutide 2.4 mg OW or placebo for 104 weeks. Co-primary endpoints related to body weight (BW) changes. Control of eating questionnaire (CoEQ) was assessed in a subgroup from Canada/USA, with scores from 19 individual items grouped into 4 domains: craving control, craving for savory, craving for sweet, or positive mood. P values for exploratory CoEQ data are unadjusted for multiplici…

Two-year Effect of Semaglutide 2.4 mg vs Placebo in Adults with Overweight or Obesity: STEP 5

2021

Obesity and diabetes-Not only a simple link between two epidemics

2018

Summary Diabetes (DM) as well as obesity, due to their increasing incidence, were recognized as epidemic by the World Health Organization. Obesity is involved not only in the aetiopathogenesis of the most common worldwide type of DM—type 2 diabetes—but also in the development of its complications. There is also increasing scientific evidence regarding the role of obesity and overweight in type 1 diabetes. Weight gain may be considered as a complication of insulin treatment but also reveals significant pathophysiological impact on various stages of the disease. Another very important aspect related to DM as well as obesity is the microbiome, which is highly variable. The function of the gut …

Pourquoi j'ai encore faim ?

2019

Comment les sensations de faim et de satiété sont produites par notre cerveau ? Quelle zone de notre cerveau va s’activer aux horaires des repas et sur la base de quelles stimulations ? À travers quelques exemples, Alexandre Benani illustrera l’importance du dialogue entre nos organes et notre cerveau dans l’élaboration de ces sensations.

L'occhio nella patologia endocrina

2014

Pelisuunnitteludokumentointi Jyväskylä Game Lab -peliprojekteissa

2017

Pelisuunnitteludokumentti (Game Design Document, GDD) on dokumentti pelisuunnittelusta, ja sen tarkoitus on organisoida pelin kehittämisprosessia monialaisen tiimin yhteistyönä. Sen pitäisi koota taiteellisen tuotteen visio ja kuvailla pelin ominaisuudet niin kattavasti että sitä voidaan käyttää luomaan ohjelmistotuote. Ongelmat GDD:ssä saattavat aiheuttaa projektitiimissä yhteisymmärryksen puutetta sekä uudelleentehtävää työtä ja yrityksessä investointien menetystä. Siten GDD:llä on olennainen rooli peliprojektin onnistumisessa. Jyväskylä Game Lab (JGL) oli projekti jonka tavoitteena on kehittää uusia koulutuksellisia metodeja pelikoulutukseen Jyväskylässä. Tämä tutkielma tutkii pelisuunni…

Structure‐ and Interaction‐Based Design of Anti‐SARS‐CoV‐2 Aptamers

2022

Aptamer selection against novel infections is a complicated and time-consuming approach. Synergy can be achieved by using computational methods together with experimental procedures. This study aims to develop a reliable methodology for a rational aptamer in silico et vitro design. The new approach combines multiple steps: (1) Molecular design, based on screening in a DNA aptamer library and directed mutagenesis to fit the protein tertiary structure; (2) 3D molecular modeling of the target; (3) Molecular docking of an aptamer with the protein; (4) Molecular dynamics (MD) simulations of the complexes; (5) Quantum-mechanical (QM) evaluation of the interactions between aptamer and target with …